Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ILT1
- Development stage
- Preclinical
- Lead developer
- Lineage Cell Therapeutics
- Modality
- Allogeneic CAR-T → CAR-T Cells → Engineered T Cells → Adoptive Cell Transfer → Cell Therapies, Allogeneic iPSCs → iPSCs → Pluripotent Stem Cells → Stem Cell Therapies → Cell Therapies, CAR-NK Cells → Other Engineered Cells → Adoptive Cell Transfer → Cell Therapies
01
Overview
ILT1 is an allogeneic islet cell therapy program being developed by Lineage Cell Therapeutics for the treatment of Type 1 Diabetes (T1D). The program focuses on the large-scale production of functional islet cells—pancreatic cells responsible for secreting hormones such as insulin and glucagon—using a proprietary dynamic culturing system. By leveraging its manufacturing capabilities, Lineage aims to overcome commercialization hurdles associated with traditional islet cell therapies. Future development plans include demonstrating compatibility with hypo-immune cell lines to potentially eliminate the need for chronic immunosuppression in clinical T1D applications.
Beyond the preview
Go deeper on ILT1.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ILT1.